Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetine

Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetine

US Patent 10653634 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C vi2025
2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of a2025
Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for2025
Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle2024
Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle2024
Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2024
Buccal formulation of avanafil with enhanced bioavailability and prolonged durat2023
Potent antimicrobial compounds with a pyridazine nucleus2023
Icariin nano-pharmaceutical formulation2023
Thioctamer expedites wound healing2022
Arylacetamides as AMP-activated protein kinase inhibitors and their use for trea2022
Methods for using 5-HMF analogs with increased solubility to inhibit or reverse 2022